Patent Protection and Pharmaceutical R&D Spending in Canada
After almost two decades of compulsory licensing of prescription drugs, Canada restored full patent protection in two legislative steps taken in 1987 and 1992. The paper investigates the impact of the strengthening of intellectual property rights on corporate R&D spending in the Canadian pharmaceutical industry. Interindustry comparisons of R&D spending trends within Canada, intercountry comparisons of R&D spending trends within the pharmaceutical industry, as well as trends in Canada's share of foreign R&D spending of US-owned multinationals suggest a statistically significant increase in Canadian pharmaceutical R&D spending after 1987.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 25 (1999)
Issue (Month): 1 (March)
|Contact details of provider:|| Postal: University of Toronto Press Journals Division 5201 Dufferin Street Toronto, Ontario, Canada M3H 5T8|
Web page: http://economics.ca/cpp/
|Order Information:|| Web: http://www.utpjournals.com/cpp/ Email: |